Clinical Trial Update: Safety and Effectiveness of a Three-Drug Combination Treatment for Recently Infected or Converted HIV Patients [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating a three-drug combination for recently infected or converted HIV patients, reporting safety and effectiveness results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 2 | Status: COMPLETED